Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Y P. Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0081-8094; OpenAlex author ID A5067941296. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2026: 3 papers

Papers 3

  1. Breaking barriers: nano-boosted drug delivery systems in overcoming the defenses of pancreatic cancer. Co-author DOI 10.1186/s12943-026-02712-8↗
  2. Correction: circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer. First author DOI 10.1186/s12943-026-02730-6↗
  3. Integrative spatiotemporal transcriptomics identifies a liver metastasis-related initial cell population associated with the SEMA3A-NRP1 axis in pancreatic duc… Co-author DOI 10.1186/s12967-026-08451-0↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ying Liu · 1 shared paper, 2026 · strength 0.43
  2. Hong‐xiang Lu · 1 shared paper, 2026 · strength 0.43
  3. Xiaofeng Guo · 1 shared paper, 2026 · strength 0.29
  4. Changhao Chen · 1 shared paper, 2026 · strength 0.29
  5. Zhihua Li · 1 shared paper, 2026 · strength 0.29
  6. Yao Kong · 1 shared paper, 2026 · strength 0.29
  7. Yuming Luo · 1 shared paper, 2026 · strength 0.29
  8. Rufu Chen · 1 shared paper, 2026 · strength 0.29
  9. Yujia Wang · 1 shared paper, 2026 · strength 0.28
  10. Wei Zhao · 1 shared paper, 2026 · strength 0.28
  11. Jie Zhou · 1 shared paper, 2026 · strength 0.28
  12. Qi Li · 1 shared paper, 2026 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.